The Human Body System Is Not Immune For Pathological Deficiencies

many different medicines are used to treat coronary heart disease. Usually they aim to reduce blood pressure or widen your arteries. For example antiplatelet are a type of medicine that can help reducing the risk of a heart attack by thinning your blood and preventing it from clotting. However there are also side effects after taking the medication like dizziness, diarrioah, nose bleeds and abdominal pain.

Angiotension II receptor blockers-decrease chemicals that narrow blood vessels allowing blood to flow easily and decreases salt and fluid build-up. Antiarrhythmic-treat abnormal heart rhythms. Antiplatelet-prevent blood clots. Aspirin- help prevent strokes and heart disease. Beta-blockers-help reduce hypertension and congestive heart

Coumadin (non specific name: warfarin) is an anticoagulant, or blood diminishing drug, that is endorsed to numerous patients who are at danger for creating blood clusters that could bring about heart assaults or strokes. Warfarin is near the most astounding purpose recently and simultaneous investigations of medications that provoke ER visits and occurring an expansion in healing center based offices with the affirmation of patients. Anticoagulation treatment stances perils to patients and over and over prompts unfavorable solution events in light of complex dosing, fundamental ensuing watching, and clashing patient consistence. As a result, various patients who meet current evidence based principles for warfarin treatment are not being managed

Aspirin – this is medication that is used to help prevent inflammation in your body and also helps prevent blood clots. This medication is important to prevent another blockage in your heart that can cause another heart

The pathophysiology of ACS includes the stable plaque forms get converted into unstable plaque forms.2 These unstable plaque forms have numerous thin fibrous cap cells, inflammatory cells, activated macrophages, and smooth muscle cells. Sympathetic activity increases myocardial contractility, pulse rate, blood pressure, and coronary blood flow which leads to plaque rupture or fissure. As the artery ruptures, it causes thrombus formation and ischemia in this particular artery. Depending on the condition, different thrombi could form. The unstable angina forms a small thrombus formation, NSTEMI forms a partial thrombus formation, and STEMI forms a complete and persistent thrombus. The risk factors involved in ACS are age, physical inactivity, and history of hypertension, diabetes, or angina. The signs of acute coronary syndromes are an acute heart failure, tachycardia, bradycardia, or heart blockage, and the symptoms of ACS consist of chest pain, pain in the extremities, nausea, shortness of breath, heavy

There are many people that suffer from venous thromboembolism. Venous thromboembolism includes both deep vein thrombosis and pulmonary embolism. This is the third most common cause of vascular death after a myocardial infarction, also known as a heart attack, and stroke. This article examines the possibility of either full or low intensity anticoagulation therapy versus aspirin. This was a randomized study that consisted of 3,396 individuals who have venous thromboembolism. These individuals either received rivaroxaban, which is an anticoagulant, or 100 mg of aspirin once a day. The individuals in this study completed 6-12 months of anticoagulation therapy and were eligible for inclusion in the study if they were 18 years of age or older. The

Value: Angiomax is a blood-thinning drug, or anticoagulant, used in emergency coronary heart care. Angiomax is positioned as an alternative to heparin, the most commonly used anticoagulant in emergency coronary heart care, so to assess Angiomax value to a hospital is required to compare these two drugs.

3.) The founders of The Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines are:

Atrial fibrillation is the most frequent cardiac arrhythmia. There has always associated risk of clot formation and embolization that can lead to ischemic stroke. A large number of these ischemic events could be prevented by timely anticoagulation. Warfarin has been used for decades for this purpose, but there are many problems for the patients due to warfarin therapy like there is continuous need of INR monitoring, many food and drug interactions of the drug, late onset of action and risk of major bleeding. Anticoagulation with the Novel oral anticoagulants e.g. Dabigatran, rivaroxaban, apixaban, endoxaban led to similar or even lower rates of ischemic stroke and major bleeding compared to an adjusted dose of warfarin (INR 2-3) in patients

For many year’s patients with atrial fibrillation have been treated with anticoagulants such as Warfarin to prevent strokes and embolisms. Unfortunately, Warfarin must be closely monitored and that is an irritant for some patients. In October 2010, the FDA approved a new generational anticoagulant drug called Dabigatran (Pradaxa). This alternate medication gives patients the benefit of no dietary restrictions since dabigatran is not affected by certain foods. Another benefit of taking dabigatran is a monthly blood test is not required to measure its effectiveness, so for this particular reason many patients switch from taking other anticoagulants to dabigatran (Talati & White, 2011). Since this medication does not require close monitoring, some wonder if is it truly a better option or can more harm than good come from taking it. While the benefits of using dabigatran have shown significant improvement over warfarin, there are still risks associated with using dabigatran.

Information to patient: Clopidogrel is an antiplatelet medication. Platelets are small blood cells that clump together during blood clotting. Prevent clotting of platelet to prevent unwanted blood clots after heart attack or stroke. Decreases risk of cardiovascular events but increases the risk of major bleeding. Swallow the tablet with a glass of water. Taken with or without food as directed by doctor. Taking the tablet at the same time each day has the best effect. It will also help you remember when to take it. Avoid this medication if active bleeding present in GI tract. Do not stop clopidogrel suddenly.

When we think of the ideal time to operate on this patient, two facts leap to attention: first, it might be unwise to proceed with surgery immediately as he has had a recent myocardial infarction, and second, that the antiplatelets need to be managed optimally to get the best outcomes possible- there is a fine line between the risk of stent thrombosis if they are stopped too early and excessive intra- and

Dual antiplatelet therapy (DAPT), especially combination therapy with aspirin and clopidogrel, is recommended for the treatment of acute coronary syndrome (ACS) and percutaneous coronary intervention (PCI).[1-2] Compared with aspirin or clopidogrel monotherapy, patients taking DAPT are much older and combine with more comorbidities. So they are more at the risk of encountering with stent thrombosis, revascularization, cardiogenic death, and so on. Antiplatelet drugs have been proved to dramatically cut down the risk of cardiovascular (CV) events, but also bring some side effects. Because antiplatelet drugs could damage gastrointestinal (GI) mucous membrane, patients are high-risk populations of overall GI adverse events that include GI bleeding,

If the patient remains at risk for further embolus immobilization from a persistent source, long-term anticoagulant therapy is recommended to prevent further acute arterial ischemic episodes within the clients. so as far as nursing implications we will go over the nursing implications as they relate to your anticoagulant therapy as a whole but just making sure that the patient is adhering to their prescribed medications that they’re on also educating the patients on any of those medications that they're not familiar with. to talk about a arterial aneurysms or aneurysms. We’re going to look at the aneurysms of central arteries, an aneurysm is an outpouching or dilation of the arterial wall and it is a common problem that involves the aorta. over time the dilated aortic wall

Uncontrolled platelet aggregation has been associated with thrombosis and subsequently with acute coronary syndromes; therefore the development of therapeutic interventions has been focused on interrupting one or several stages in hemostasis, platelet aggregation and/or coagulation. 3